Skip to main content

Table 1 Clinical characteristics, blood-test data, and co-existing diseases in patients with angiodysplasia and gastric antral vascular ectasia (GAVE)

From: Comparison of argon plasma coagulation in management of upper gastrointestinal angiodysplasia and gastric antral vascular ectasia hemorrhage

 

Angiodysplasia

N = 27

GAVE

N = 19

P value

Age, years, mean ± SD*

71.6 ± 10.2

61.8 ± 11.9

0.005

Gender, M/F

15/12

11/8

0.875

Hemoglobin level (g/L), mean ± SD*

84.0 ± 32.0

82.0 ± 21.0

0.971

Platelet count (×109/L), mean ± SD*

162.3 ± 84.2

142.1 ± 111.4

0.192

Prothrombin time (sec), mean ± SD*

11.1 ± 1.5

11.1 ± 3.3

0.551

Activated partial thromboplastin time (sec), mean ± SD*

30.1 ± 5.1

27.0 ± 2.8

0.095

Active blood oozing on endoscopy, n (%)

19 (70.4)

17 (89.5)

0.160

Liver cirrhosis, n (%)

7 (25.9)

12 (63.2)

0.012

End-stage renal disease, n (%)

6 (22.2)

2 (10.5)

0.440

Hepatoma, n (%)

5 (18.5)

7 (36.8)

0.19

§Transarterial embolization, n (%)

2 (7.4)

6 (31.6)

0.051

§Radiation therapy, n (%)

1 (3.7)

5 (26.3)

0.068

  1. * SD: 1 standard deviation
  2. § as previous treatment for hepatoma